Viral pneumonia diagnostics: Moscow started testing the innovative software

July 1

Moscow started testing innovative software that, according to preliminary data, can diagnose viral pneumonia. It was created by one of the largest developers of microelectronics in Russia that is the management company of the Moscow’s Modul technopark. The tests are carried out at the  Pirogov National Medical and Surgical Center as part of a pilot testing program for innovative solutions.

The Module Technopark’s software can independently recognize lung pathologies, including those caused by coronavirus infection, based on X-rays. The software uses a neural network with the U-Net architecture for image segmentation. Before commencement of the pilot tests, the neural networks were trained using databases of the A.I.  Burnazyan Federal Medical Biophysical Center.

The system can determine the volume, area and extent of respiratory damage. The doctor just needs to feed the electronic X-ray to the software. Data processing takes only a few minutes.

If the pilot testing proves the technology efficiency, the innovative software will significantly save doctors' time. They will only need to study results of the diagnostics and prescribe a treatment; they will not need to work with numerous X-ray images.

If testing is successful, the new software will probably be used in other medical institutions in Moscow.

In addition, the development company is planning to expand the functionality of its product. The software can be applied not only in pulmonology, but in other fields of medicine too. For example, it will process results of magnetic resonance imaging, computed tomography and mammography. The system will help detect brain and breast cancer, Alzheimer's disease, stenosis and other diseases.

The Moscow Innovation Agency is the program operator. It was launched in 2019. Thanks to the program, startups and successful companies can test their products at urban or commercial sites. This allows entrepreneurs to assess the competitiveness and prospects of developments and further improve them before entering the market, with consumers’s feedback taken into account. Whereas the companies that take part in testing are the first to get acquainted with emerging technologies.

“The pilot testing program involves more than 130 government and commercial sites from 18 industries, including medicine and patient rehabilitation. Since 2019, 79 pilot tests have already been completed, and another 33 are now being implemented. The program enables testing of innovative technologies in practice, understand their efficiency and prepare for use in everyday life,” said Alexei Fursin, Head of the Moscow Department of Entrepreneurship and Innovative Development.

The pilot testing sites include the Moscow Technopolis, banks, chain stores and other organizations.



If you continue to use our website, you are agreeing to accept the use of cookies on your device. Cookie files ensure the website’s efficiency and help us provide you with the most interesting and relevant information. Read more about cookie files.
Accept ccokies